Showing results (1071-1080 of 6,501) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Altered biodistribution of indium-111-labeled monoclonal antibody 96.5 to tumors and normal tissues of nude mice bearing human melanoma xenografts in visceral organsD R McCready, J Price, C M Balch, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
In vitro differentiation and antigenic changes in human melanoma cell linesL Guarini, M Temponi, G M Edwalds, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Comparative effects of fagaronine, adriamycin and aclacinomycin on K562 cell sensitivity to natural-killer-mediated lysis. Lack of agreement between alteration of transferrin receptor and CD15 antigen expressions and induction of resistance to natural killerH Benoist, L Comoe, P Joly, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Distribution of radiolabelled monoclonal antibody Po66 after intravenous injection into nude mice bearing human lung cancer graftsB Desrues, B Collet, M P Ramé, et al.Cancer Immunology, Immunotherapy : CII|September 21, 2015
Modification of cytokine-induced killer cells with chimeric antigen receptors (CARs) enhances antitumor immunity to epidermal growth factor receptor (EGFR)-positive malignanciesXuequn Ren, Wanli Ma, Hong Lu, et al.Cancer Immunology, Immunotherapy : CII|September 23, 2015
Defining the effects of age and gender on immune response and outcomes to melanoma vaccination: a retrospective analysis of a single-institution clinical trials' experienceAdriana G Ramirez, Nolan A Wages, Yinin Hu, et al.Cancer Immunology, Immunotherapy : CII|October 27, 2015
Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patientsLuciane Zabijak, Christophe Attencourt, Caroline Guignant, et al.Cancer Immunology, Immunotherapy : CII|January 27, 2016
Selection and expansion of natural killer cells for NK cell-based immunotherapyPetra S A Becker, Garnet Suck, Paulina Nowakowska, et al.Cancer Immunology, Immunotherapy : CII|January 31, 2016
Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinicKinga Majchrzak, Michelle H Nelson, Stefanie R Bailey, et al.Cancer Immunology, Immunotherapy : CII|February 7, 2016
CD57 in human natural killer cells and T-lymphocytesHassen Kared, Serena Martelli, Tze Pin Ng, et al.Pageof 651